Article Details

Novartis Deals in Cardio Again, Dropping $1.4B to Acquire Tourmaline - BioSpace

Retrieved on: 2025-09-09 12:53:50

Tags for this article:

Click the tags to see associated articles and topics

Novartis Deals in Cardio Again, Dropping $1.4B to Acquire Tourmaline - BioSpace. View article details on hiswai:

Excerpt

The centerpiece of the acquisition is pacibekitug, an investigational monoclonal antibody that works by targeting the IL-6 protein and is being ...

Article found on: www.biospace.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo